FULLER H B CO
H.B. Fuller formulates, manufactures and markets adhesives, sealants and other specialty chemical products for customers in consumer goods, construction and industrial markets. Its products include industrial adhesives used in goods such as food and beverage containers, medical products, appliances, vehicles, electronics and aerospace products, along with construction sealing and waterproofing solutions, roofing adhesives, tapes and sealants. The company also provides technical support and solutions tailored to customer needs. As of the beginning of fiscal 2025, H.B. Fuller’s operating segments are Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Building Adhesive Solutions. It sells products through direct deliveries from manufacturing and distribution facilities, as well as through distributors. Sales operations span 34 countries, and as of November 29, 2025, it has sales offices and manufacturing plants in 24 countries outside the United States and satellite sales offices in another 9 countries. H.B. Fuller is headquartered in St Paul, Minnesota.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
H.B. Fuller (FUL) announced progress on its Project Quantum Leap, reducing global facilities from 82 to 64 by Q3 2026, with plans to reach 55 by 2030. The initiative aims for $75M in annual cost savings by 2030, with $25M expected by 2026. The company is investing $100M through 2026 and expects lower operating costs and reduced shipping points. FUL reported $3.5B in 2025 revenue and employs over 7,100 people.
H.B. Fuller (FUL) is ranked 7th on a list of activist target stocks for potential spin-offs or breakups. Activist investors argue that divesting underperforming divisions could unlock shareholder value. H.B. Fuller's diversified adhesives business and global operations make it a target for Ancora Holdings Group and Engine Capital, who are pushing for strategic alternatives.
Ancora Holdings Group urged H.B. Fuller Company (FUL) to explore strategic alternatives, including a full sale, after its $1.2B-$1.4B offer for the Building Adhesive Solutions segment was rejected. Ancora criticized FUL's board for limited engagement and noted a 27% share price decline over five years. FUL has not responded to the letter.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning FUL (FULLER H B CO). Coverage has skewed bullish: 2 bullish, 0 neutral, and 1 bearish.
Recent FUL coverage spans mergers & acquisitions, corporate actions and financial news.
In the last 30 days, FUL insiders filed 1 SEC Form 4 transaction — 1 purchase ($25K) and no sales. The most active reporter was Malik Muhammad Shahbaz, Senior VP, BAS, with 1 filing.
Cost‑reduction initiative should improve margins and may lift the stock.
Activist pressure may drive the stock lower as investors anticipate restructuring or a sale.
The rejected bid signals potential pressure on H.B. Fuller’s share price and opens the door for a full‑company takeover, creating volatility.
The large debt raise increases leverage and may pressure the stock, while the loan termination removes a financing source.
Small insider purchase may signal confidence but size is negligible.
AlphAI scores every news story that mentions FUL with an AI model for sentiment and relevance, and aggregates insider trades from FULLER H B CO's SEC EDGAR Form 4 filings. Figures refresh continuously.
H.B. Fuller (FUL) announced progress on its Project Quantum Leap, reducing global facilities from 82 to 64 by Q3 2026, with plans to reach 55 by 2030. The initiative aims for $75M in annual cost savings by 2030, with $25M expected by 2026. The company is investing $100M through 2026 and expects lower operating costs and reduced shipping points. FUL reported $3.5B in 2025 revenue and employs over 7,100 people.
H.B. Fuller (FUL) is ranked 7th on a list of activist target stocks for potential spin-offs or breakups. Activist investors argue that divesting underperforming divisions could unlock shareholder value. H.B. Fuller's diversified adhesives business and global operations make it a target for Ancora Holdings Group and Engine Capital, who are pushing for strategic alternatives.
Ancora Holdings Group urged H.B. Fuller Company (FUL) to explore strategic alternatives, including a full sale, after its $1.2B-$1.4B offer for the Building Adhesive Solutions segment was rejected. Ancora criticized FUL's board for limited engagement and noted a 27% share price decline over five years. FUL has not responded to the letter.
FULLER H B CO (FUL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 21, 2026, H.B. Fuller Company, a Minnesota corporation (the “Company”), completed the issue and sale of $850,000,000 aggregate principal amount of its 7.625% Notes due 2034 (the “Notes”) pursuant to its previously a
Malik Muhammad Shahbaz (Senior VP, BAS) purchased 479 shares of FULLER H B CO (FUL) at $52.23 on 2026-10-16.
FULLER H B CO (FUL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 H.B. Fuller Board Unanimously Rejects Second Unsolicited, Non-Binding Proposal for Building Adhesive Solutions Segment Announces market check for select market segments ST. PAUL, Minn.--(BUSINESS WIRE)-- H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL
H.B. Fuller (FUL) rejected a $1.2B–$1.4B bid for its Building Adhesive Solutions unit from Ancora and plans to explore market interest in other segments. The company views BAS as strategically important and will use any proceeds for debt reduction.
H.B. Fuller (FUL) proposed a cash acquisition of Advanced Medical Solutions (AMS) via a scheme of arrangement, with terms to be disclosed June 25, 2026. FUL insiders bought over $600K of stock in late September, near its 52-week low. The company yields ~2% and has a payout ratio under 30%.
FULLER H B CO (FUL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 H.B. Fuller Announces Pricing of $850 Million Debt Offering ST. PAUL, Minn., Oct. 8, 2026 – H.B. Fuller Company (“H.B. Fuller”) (NYSE:FUL) announced today that it has priced an offering of $850 million aggregate principal amount of 7.625% new senior unsecured notes d
H.B. Fuller Company (NYSE:FUL) priced an $850 million senior unsecured notes offering due 2034 at 7.625% interest. Proceeds will fund the acquisition of Advanced Medical Solutions Group, repay borrowings, and cover general corporate purposes. The notes are subject to a conditional redemption tied to the acquisition's completion by June 25, 2027.
